# CPI Aerostructures Inc: Form 10-Q for the period ended Mar 31, 2025

- Company: [CPI Aerostructures Inc](/companies/cvu.md) (CIK 889348)
- Form: 10-Q
- Filed: 2025-05-15
- Accepted by EDGAR: May 15, 2025, 16:40 ET
- Period: 2025-03-31
- Accession: 0001999371-25-006227
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/889348/000199937125006227/cpi-10q_033125.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/889348/000199937125006227/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-03-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2025-01-01 to 2025-03-31 | $15.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months, 2025-01-01 to 2025-03-31 | $13.8m | us-gaap:CostOfRevenue |
| Gross profit | 3 months, 2025-01-01 to 2025-03-31 | $1.6m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months, 2025-01-01 to 2025-03-31 | $2.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2025-01-01 to 2025-03-31 | −$1.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2025-01-01 to 2025-03-31 | $488.1k | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months, 2025-01-01 to 2025-03-31 | −$349.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2025-01-01 to 2025-03-31 | −$1.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months, 2025-01-01 to 2025-03-31 | −$0.10 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2025-01-01 to 2025-03-31 | −$0.10 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2025-01-01 to 2025-03-31 | 12,720,148 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2025-01-01 to 2025-03-31 | −$2.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2025-01-01 to 2025-03-31 | $59.4k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2025-03-31 | $1.9m | us-gaap:Cash |
| Current assets | at 2025-03-31 | $41.1m | us-gaap:AssetsCurrent |
| Total assets | at 2025-03-31 | $65.4m | us-gaap:Assets |
| Current liabilities | at 2025-03-31 | $26.2m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2025-03-31 | $40.4m | us-gaap:Liabilities |
| Shareholders' equity | at 2025-03-31 | $24.9m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 21,544 characters.

The following discussion should be read in conjunction with the Company’s consolidated financial statements and notes thereto contained in this report.

### Forward Looking Statements

When used in this Form 10-Q and in future filings by us with the Securities and Exchange Commission (the “SEC”), the words or phrases “will likely result,” “management expects” or “we expect,” “will continue,” “is anticipated,” “estimated” or similar expressions are intended to identify “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties that could cause actual results to differ materially from historical earnings and those presently anticipated or projected. The risks are included in Part I, Item 1A – Risk Factors of our Annual Report on Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). We have no obligation to publicly release the result of any revisions which may be made to any forward-looking statements to reflect anticipated or unanticipated events or circumstances occurring after the date of such statements.

### Business Operations

We are engaged in the contract production of structural aircraft parts for fixed wing aircraft and helicopters in both the commercial and defense markets. We also have a strong and growing presence in the aerosystems sector of the market, with our production of various reconnaissance pod structures and fuel panel systems. Within the global aerostructure and aerosystem supply chain, we are either a Tier 1 supplier to aircraft original equipment manufacturers (“OEMs”) or a Tier 2 subcontractor to major Tier 1 manufacturers. We also are a prime contractor to the United States Department of Defense (“DOD”), primarily the United States Air Force (“USAF”). In conjunction with our assembly operations, we provide engineering, program management, supply chain management and kitting, and MRO.

### Recent Developments

On May 14, 2025, the Company obtained a waiver from its lenders under its existing Credit Agreement with respect to financial covenant noncompliance as of March 31, 2025. For additional information, see “*Liquidity and Capital Resources — Bank Credit Facilities”* below.

### Backlog

We produce custom assemblies pursuant to long-term contracts and customer purchase orders. Funded backlog consists of aggregate funded values under such contracts and purchase orders, excluding the portion previously included in operating revenues pursuant to Accounting Standards Codification Topic 606 (“ASC 606”). Unfunded backlog is the estimated amount of future orders under the expected duration of the programs. Substantially all of our backlog is subject to termination at will and rescheduling, without significant penalty. Funds are often appropriated for programs or contracts on a yearly or quarterly basis, even though the contract may call for performance that is expected to take a number of years. Therefore, our funded backlog does not include the full value of our contracts.

Our total backlog as of March 31, 2025 and December 31, 2024 is shown below.

| Backlog (Total) | March 31, 2025 | December 31, 2024 |
| --- | ---: | ---: |
| Funded | $82,165,000 | $85,039,000 |
| Unfunded | 433,750,000 | 425,232,000 |
| Total | $515,915,000 | $510,271,000 |

Approximately 96% of the total amount of our backlog at March 31, 2025 was attributable to government and military contractor contracts. Our backlog attributable to government contracts at March 31, 2025 and December 31, 2024 was as follows:

| Backlog (Government) | March 31, 2025 | December 31, 2024 |
| --- | ---: | ---: |
| Funded | $79,251,000 | $82,262,000 |
| Unfunded | 417,354,000 | 404,256,000 |
| Total | $496,605,000 | $486,518,000 |

13

Our backlog attributable to commercial contracts at March 31, 2025 and December 31, 2024 was as follows:

| Backlog (Commercial) | March 31, 2025 | December 31, 2024 |
| --- | ---: | ---: |
| Funded | $2,914,000 | $2,777,000 |
| Unfunded | 16,397,000 | 20,976,000 |
| Total | $19,311,000 | $23,753,000 |

The total backlog at March 31, 2025 is primarily comprised of long-term programs with Raytheon (Next Generation Jammer-Mid Band Pods and Advanced Tactical Pods), Lockheed Martin (F-16 RI/DCC’s), L3Harris (Next Generation Jammer-Low Band Pods), Raytheon (B-52 Radar Racks), Sikorsky (UH-60 BLACKHAWK Stabilator MRO) and USAF (T-38 Classic Structural Modification Kits).

The funded backlog at March 31, 2025 is primarily from purchase orders under long-term contracts with Raytheon (NGJ – Mid Band Pods and Advanced Tactical Pods), USAF (T-38 Classic Structural Modification Kits), L3Harris (Next Generation Jammer-Low Band Pods), Sikorsky (UH-60 BLACKHAWK Gunner Windows) and Lockheed Martin (F-16 RI/DCC’s).

### Critical Accounting Estimates

We make a number of significant estimates, assumptions and judgments in the preparation of our financial statements. See *Management’s Discussion and Analysis of Financial Condition and Results of Operations* in the Form 10-K, for a discussion of our critical accounting estimates. There have been no significant changes to the application of our critical accounting estimates during the quarter ended March 31, 2025.

### Results of Operations

### Revenue

Total Revenue for the three months ended March 31, 2025 was $15,400,608 compared to $19,081,143 for the same period last year, a decrease of $3,680,535 or 19.3%, driven primarily by unfavorable adjustments on our A-10 Main Landing Gear Pods program due to increased labor and material costs.

Revenue from military subcontracts was $11,326,608 for the three months ended March 31, 2025 compared to $15,001,768 for the three months ended March 31, 20024, a decrease of $3,675,160 or 24.5%, driven primarily by unfavorable adjustments on our A-10 Main Landing Gear Pods program due to increased labor and material costs.

Revenue from government military contracts was $2,793,612 for the three months ended March 31, 2025 compared to $2,781,881 for the three months ended March 31, 2024, a decrease of $11,731 or 0.4%, driven primarily by a decrease in our USAF T-38 Pacer Classic Structural Modification Kits program due to timing of material receipts.

Revenue from commercial subcontracts was $1,280,388 for the three months ended March 31, 2025 compared to $1,297,494 for the three months ended March 31, 2024, a decrease of $17,106 or 1.3%, driven primarily by a decrease in our Embraer Phenom-300 Engine Inlet Assemblies program.

### Cost of Sales

Total Cost of Sales for the three months ended March 31, 2025 and 2024 was $13,751,133 and $15,527,394, respectively, a decrease of $1,776,261 or 11.4%.

The components of the cost of sales were as follows:

|  | Three months ended March 31, 2025 | March 31, 2024 |
| --- | ---: | ---: |
| Procurement | $8,294,588 | $9,365,019 |
| Labor | 1,642,586 | 1,797,790 |
| Factory overhead | 4,118,581 | 4,267,095 |
| Other cost of sales | (304,622) | 97,490 |
| **Cost of sales** | $13,751,133 | $15,527,394 |

14

Procurement for the three months ended March 31, 2025 was $8,294,588 compared to $9,365,019 for the three months ended March 31, 2024, a decrease of $1,070,431 or 11.4%, driven primarily by lower material receipts for Embraer Phenom-300 Engine Inlet Assemblies program and the Collins MS-110 program.

Labor costs for the three months ended March 31, 2025 were $1,642,586 compared to $1,797,790 for the three months ended March 31, 2024, a decrease of $155,204 or 8.6% primarily driven by decrease in work performed in Embraer Phenom-300 Engine Inlet Assemblies program.

Factory overhead for the three months ended March 31, 2025 was $4,118,581 compared to $4,267,095 for the three months ended March 31, 2024, a decrease of $148,514 or 3.5%.

Other cost of sales relates to items that can increase or decrease cost of sales such as changes in inventory reserves, changes in loss contract provisions, absorption variances and direct charges to cost of sales. Other cost of sales for the three months ended March 31, 2025 was $(304,622) compared to a $97,490 for the three months ended March 31, 2024, a decrease of $402,112 or 412.5%. The decrease is primarily the result benefits realized on programs nearing completion and lower loss reserve requirements during the three months ended March 31, 2025 as compared to the three months ended March 31, 2024.

### Gross Profit

Gross profit and gross profit percentage (“gross margin”) for the three months ended March 31, 2025 and March 31, 2024 was $1,649,475 and 10.7% compared to $3,553,749 and 18.6%, respectively, a decrease of $1,904,274, or 53.6%, and 790 basis points for the reasons noted above associated with the A-10 program. Excluding the A-10 impact, current year gross margin would be 21.6% compared to 18.6% in the first quarter of 2024.

### Favorable/Unfavorable Adjustments to Gross Profit

During the three months ended March 31, 2025 and 2024, circumstances required that we make changes in estimates to various contracts. Such changes in estimates resulted in changes in total gross profit as follows:

|  | Three months ended March 31, 2025 | March 31, 2024 |
| --- | ---: | ---: |
| Net adjustments | $(3,129,230) | $(1,172,861) |

The net adjustment of $3.1 million for the three months ended March 31, 2025 is driven primarily by a decrease of $2.1 million on the A-10 program as a result of increased labor and material costs.

### Selling, General and Administrative Expenses

Selling, general and administrative expenses for the three months ended March 31, 2025 were $2,835,777 compared to $2,713,904 for the three months ended March 31, 2024, an increase of $121,873 or 4.5%. The increase was primarily the result of higher accounting and professional fees.

### Interest expense

Interest expense for the three months ended March 31, 2025 was $488,091, compared to $632,135 for the three months ended March 31, 2024, a decrease of $144,044 or 22.8%. The decrease was the result of lower year-over-year interest rates charged on our outstanding debt under the Credit Agreement, combined with a year-over-year decrease in the amount of our outstanding debt under the Credit Agreement.

### (Loss) income Before Provision for Income Taxes

(Loss) income before provision for income taxes for the three months ended March 31, 2025 was $(1,672,893) compared to $207,710 for the three months ended March 31, 2024, a decrease of $1,880,603 or 905.4% for the reasons noted above.

### (Benefit)/Provision for Income Taxes

(Benefit) for income taxes for the three months ended March 31, 2025 was $(348,969) compared to provision for income taxes of $39,472 for the three months ended March 31, 2024, an increase of $388,441 or 984.1%.

The effective income tax rate for the three months ended March 31, 2025 and 2024 20.9% and 19.0%. The change in effective tax rate is result of the varying levels of income in each year and the relative impact of the R&D credit, state income taxes and permanent tax differences.

The effective income tax rate for the three months ended March 31, 2025 is 20.9%. The difference between the effective income tax rate for the three months ended March 31, 2025, and the statutory income tax rate of 21% is primarily due to estimated R&D credit, state income taxes and permanent tax differences.

The effective income tax rate for the three months ended March 31, 2024 is 19.0%. The difference between the effective income tax rate for the three months ended March 31, 2024, and the statutory income tax rate of 21% is primarily due to estimated R&D credit, state income taxes and permanent tax differences.

### Net (Loss)/Income and Earnings per Share

Net (loss) income for the three months ended March 31, 2025 was $(1,323,924) or $(0.10) per basic share, compared to net income of $168,238 or $0.01 per basic share, for the same period last year. Diluted (loss) per share was $(0.10) for the three months ended March 31, 2025 calculated utilizing 12,720,148 weighted average shares outstanding. Diluted income per share was $0.01 for the three months ended March 31, 2024 calculated utilizing 12,680,584 weighted average shares outstanding. The decrease in net income was primarily driven by a decrease in gross profit.

### Liquidity and Capital Resources

### General

At March 31, 2025, we had working capital of $14,951,205 compared to $17,122,111 at December 31, 2024, a decrease of $2,170,906 or 12.7%. The decrease was driven primarily by a decrease in cash partly offset by an increase in accounts receivable.

### Cash Flow

A large portion of our cash flow is used to pay for materials and processing costs associated with contracts that are in process and which do not provide for progress payments. Costs and related earnings for which we do not bill on a progress basis, and which, as a result, we bill upon shipment of products, are components of contract assets on our consolidated balance sheets and represent the aggregate costs and related earnings for uncompleted contracts for which the customer has not yet been billed. These costs and earnings are recovered upon shipment of products and presentation of billings in accordance with contract terms.

Because ASC 606 requires us to use estimates in determining revenue, costs and profits and in assigning the amounts to accounting periods, there can be a significant disparity between earnings (both for accounting and tax purposes) as reported and actual cash that we receive during any reporting period. Accordingly, it is possible that we may have a shortfall in our cash flow and may need to borrow money or take steps to defer cash outflows until the reported earnings materialize into actual cash receipts.

Some of our programs require us to expend up-front costs that may have to be amortized over a portion of production units. In the case of significant program delays and/or program cancellations, we could experience margin degradation, which may be material for costs that are not recoverable. Such charges and the loss of up-front costs could have a material impact on our liquidity and results of operations.

We continuously work to improve our payment terms from our customers, including accelerated progress payment arrangements, as well as exploring alternate funding sources.

At March 31, 2025, we had cash of $1,868,580 compared to $5,490,963 at December 31, 2024, a decrease of $3,622,383 or 65.9%. This decrease was primarily the result of cash flow used in operating activities and repayment of debt.

### Bank Credit Facilities

On March 24, 2016, the Company entered into an Amended and Restated Credit Agreement with the lenders named therein and BankUnited N.A. as Sole Arranger, Agent and Collateral Agent (as amended from time to time, the “Credit Agreement” or the “BankUnited Facility”). The Credit Agreement originally provided for a revolving credit loan commitment of $30 million (the “Revolving Loan”) and a $10 million term loan (“Term Loan”). The Revolving Loan bears interest at a rate as defined in the Credit Agreement.

On February 20, 2024, the Company entered into a Thirteenth Amendment to the Credit Agreement (the “Thirteenth Amendment”). Under the Thirteenth Amendment, the parties amended the Credit Agreement by (a) extending the maturity date of the Company’s existing revolving line of credit to August 31, 2025; and (b) setting the aggregate maximum principal amount of all revolving line of credit loans to $19,800,000 from January 1, 2024 through March 31, 2024, $19,080,000 from April 1, 2024 through June 30, 2024, $18,360,000 from July 1, 2024 through September 30, 2024, $17,640,000 from October 1, 2024 through December 31, 2024, $16,920,000 from January 1, 2025 through March 31, 2025, $16,200,000 from April 1, 2025 through June 30, 2025 and $15,480,000 from July 1, 2025 onward, and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period.

On November 13, 2024, the Company entered into a Fourteenth Amendment to the Credit Agreement (the “Fourteenth Amendment”). Under the Fourteenth Amendment, the parties amended the Credit Agreement by: (i) extending the maturity date of the Company’s existing revolving line of credit (the “Revolving Credit Loans”) to August 31, 2026; (ii) reducing the Base Rate Margin (as defined in the Credit Agreement) from 3.50% to 2.0%; (iii) resetting the aggregate maximum principal amount of all Revolving Credit Loans to $16,890,000 from January 1, 2025 through March 31, 2025, $16,140,000 from April 1, 2025 through June 30, 2025, $15,390,000 from July 1, 2025 through September 30, 2025, $14,640,000 from October 1, 2025 through December 31, 2025, $13,890,000 from January 1, 2026 through March 31, 2026, $13,140,000 from April 1, 2026 through June 30, 2026, and $12,390,000 from July 1, 2026 onward and for payments to be made by the Company to comply therewith (if any such payments are necessary), on the first day of each such period; and (iv) requiring the Company, if it does not deliver to BankUnited, N.A. by December 31, 2025, a commitment letter with banks and terms and conditions reasonably acceptable to the Lenders for refinancing the obligations under the Credit Agreement, to make a payment by January 31, 2026, equal to 2% of the aggregate outstanding principal amount of the Revolving Credit Loans as of December 31, 2025, with 50% of such payment applied to reduce the aggregate outstanding principal and the remaining 50% retained by the Lenders as an amendment fee with respect to the Fourteenth Amendment.

The Credit Agreement, as amended, requires us to maintain the following financial covenants: (a) minimum debt service coverage ratio of no less than 1.5 to 1.0 for trailing four fiscal quarter periods; (b) maximum leverage ratio of no less than 4.0 to 1.0 for trailing four fiscal quarter periods; (c) minimum net income after taxes as of the end of each fiscal quarter being no less than $1.00; and (d) a minimum adjusted EBITDA at the end of each fiscal quarter of no less than $1.0 million. As of March 31, 2025, the Company was not in compliance with the financial covenants described in items (a), (c) and (d) above. The noncompliance constituted events of default under the Credit Agreement. On May 14, 2025, the Company obtained a written waiver from the Lenders waiving the specified covenant defaults for the fiscal quarter ended March 31, 2025. A copy of the waiver letter is filed as Exhibit 10.1 to this Quarterly Report on Form 10-Q. Although the waiver cured the defaults for the first quarter, failure to comply with the financial covenants in future periods could result in additional events of default, and unless further waivers or amendments are obtained, of which there is no assurance of obtaining such waivers in the future could permit the lenders to accelerate the Company’s outstanding obligations under the Credit Agreement and exercise other remedies available under the loan documents. The Company continues to monitor its financial performance and covenant compliance and may seek further waivers or amendments if necessary.

The BankUnited Facility is secured by all of the Company’s assets and both the Revolving Loan and Term Loan bear interest at the Prime Rate + 2.0% per the 14th Amendment effective on November 13, 2024. The Prime Rate was 7.50% as of March 31, 2025 and as such, the Company’s interest rate on the Revolving Loan and Term Loan was 9.50% as of March 31, 2025.

As of March 31, 2025 and December 31, 2024, the Company had $16,640,000 and $17,390,000 outstanding under the Revolving Loan, respectively.

There is currently no availability for borrowings under the Revolving Loan and the Company finances its operations from internally generated cash flow.

### Liquidity

We believe that our existing resources as of March 31, 2025 will be sufficient to meet our current working capital needs for at least the next 12 months from the date of issuance of our consolidated financial statements. However, our working capital requirements can vary significantly, depending in part on the timing of new program awards and the payment terms with our customers and suppliers. If our working capital needs exceed our cash flows from operations, we would look to our cash balances and availability for borrowings under our borrowing arrangement to satisfy those needs, as well as potential sources of additional capital, which may not be available on satisfactory terms and in adequate amounts, if at all.

### Contractual Obligations

For information concerning our contractual obligations, see *Contractual Obligations* under Item 7 of Management’s Discussion and Analysis of Financial Condition and Results of Operations of the Form 10-K.

### Inflation

Inflation historically has not had a material effect on our operations, although the current inflationary environment in the U.S., and its impact on interest rates, supply chain, labor markets and general economic conditions, are factors that the Company actively monitors in an attempt to mitigate and manage potential negative impacts on and risks faced by the Company. The majority of the Company’s long term contracts with its customers and suppliers reflect fixed pricing. When bidding for work, the Company takes inflation risk and supply side pricing risk into account in its proposals.

## Controls and procedures

As filed, 2,359 characters.

Management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting, as defined in Exchange Act Rules 13a-15(f) and 15d-15(f), is a process designed by, or under the supervision of, our principal executive and principal financial officers and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that:

- pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of our assets;
- provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with U.S. GAAP, and that our receipts and expenditures are being made only in accordance with authorizations of our management and directors; and
- provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our consolidated financial statements.

Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Management conducted an evaluation of the effectiveness of internal control over financial reporting based on criteria established in *Internal Control- Integrated Framework* (2013) issued by the Committee of Sponsoring Organizations of the Treadway Commission (“COSO”). Based on this evaluation, management concluded that the Company’s internal control over financial reporting was effective at the reasonable assurance level as of March 31, 2025.

### Changes in Internal Control Over Financial Reporting

There were no changes in our internal control over financial reporting during the quarter ended March 31, 2025 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 359 characters.

“Part I Item 1A - Risk Factors” of our Comprehensive Form 10-K for the year ended December 31, 2024, includes a discussion of significant factors known to us that could materially adversely affect our business, financial condition, or results of operations. There have been no material changes from the risk factors described in such report except as follows.

Filed May 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001999371-25-006227. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.
